Method For Protecting Humans Against Superficial Vasodilator Flush Syndrome


Methods for protection of a human from SVFS comprise the administration of a flavonoid compound of the basic structures 2-phenyl-4H-1-benzopyran or 2-phenyl-4-keto-1-benzopyran or glycosides thereof, alone or, optionally, together with one or more of an olive kernel extract, a non-bovine sulfated proteoglycan, bitter willow extract, a D-hexosamine sulfate, S-adenosylmethionine, folic acid, vitamin B12 and a serotonin inhibitor. Such treatment prevents, reduces or eliminates SVFS in patients receiving as much as 300-3000 mg/day of niacin therapeutically, whether administered prior to, or along with, an anti-SVFS composition.

Download PDF
Document Preview
Document History
  • Publication: Apr 12, 2011
  • Application: May 6, 2008
    US US 15126808 A
  • Priority: May 6, 2008
    US US 15126808 A
  • Priority: Dec 10, 2007
    US US 99999107 A
  • Priority: Jan 10, 2007
    US US 65116107 A
  • Priority: Mar 30, 2004
    US US 81182804 A

Download Citation

Sign in to the Lens